| abstract |
The idarubicin hydrochloride ω-type new compound of the present invention has less hygroscopicity, better storage stability, and is more conducive to drug quality control, etc., and is suitable for the preparation of acute leukemia, advanced breast cancer, and diffuse large B in the central nervous system. cell lymphoma, non-Hodgkin's lymphoma, myelodysplastic syndrome, lung cancer, melanoma, soft tissue sarcoma, multiple myeloma, liver cancer, colorectal cancer, kidney cancer, prostate cancer, endometrial cancer, testicular tumor, Use in medicines for the treatment or prevention of ovarian cancer, head and neck cancer, and the like. |